GeneTex—Recombinant Antibodies for SARS-CoV-2

 

Product Intro.

 

GeneTex, an antibody manufacturer for more than two decades, has augmented its extensive catalog of COVID-19 reagents with the production of recombinant antibodies targeting the viral spike (S) and nucleocapsid (N) proteins. Generated in its state-of-the-art recombinant antibody facility, all these novel recombinant antibodies against the SARS-CoV-2 S and N proteins exhibit high affinity and specificity. The antibodies are validated for WB, ICC/IF, and as antibody pairs for sandwich ELISA.